Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.
公司代码AAPG
公司Ascentage Pharma Group International
CEOYang (Dajun)
网址https://www.ascentage.cn/
常见问题
Ascentage Pharma Group International(AAPG)的当前股价是多少?
Ascentage Pharma Group International(AAPG)的当前股价是 26.980。
Ascentage Pharma Group International的股票代码是什么?
Ascentage Pharma Group International的股票代码是AAPG。
Ascentage Pharma Group International股票的52周最高点是多少?
Ascentage Pharma Group International股票的52周最高点是48.450。
Ascentage Pharma Group International股票的52周最低点是多少?
Ascentage Pharma Group International股票的52周最低点是16.500。
Ascentage Pharma Group International的市值是多少?
Ascentage Pharma Group International的市值是--。
Ascentage Pharma Group International的净利润是多少?
Ascentage Pharma Group International的净利润为--。
现在Ascentage Pharma Group International(AAPG)的股票是买入、持有还是卖出?
根据分析师评级,Ascentage Pharma Group International(AAPG)的总体评级为--,目标价格为--。
Ascentage Pharma Group International(AAPG)股票的每股收益(EPS TTM)是多少
Ascentage Pharma Group International(AAPG)股票的每股收益(EPS TTM)是--。